Top

Graefe's Archive for Clinical and Experimental Ophthalmology

Published in:

01-10-2020 | Basalioma | Letter to the Editor

Effective treatment of locally advanced periocular basal cell carcinoma with oral hedgehog pathway inhibitor?

Authors: Xiaoyi Hou, Alexander C. Rokohl, Monika Ortmann, Ludwig M. Heindl

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 10/2020

Excerpt

Dear Editor, …

Rokohl AC, Löser H, Mor JM, Loreck N, Koch KR, Heindl LM (2020) Young male patient with unusual space-occupying lesion of the lower eyelid. Ophthalmologe 117:73–77. https://doi.org/10.1007/s00347-019-00948-yCrossRefPubMed

Lang BM, Balermpas P, Bauer A et al (2019) S2k guidelines for cutaneous basal cell carcinoma - part 2: treatment, prevention and follow-up. J Dtsch Dermatol Ges 17:214–230. https://doi.org/10.1111/ddg.13755CrossRefPubMed

Kopecky A, Rokohl AC, Heindl LM (2018) Techniques for the reconstruction of the posterior eyelid lamella. Klin Monbl Augenheilkd 235:1415–1428. https://doi.org/10.1055/a-0751-1069CrossRefPubMed

Rokohl AC, Koch KR, Mor JM, Loreck N, Schlaak M, Mauch C, Bechrakis NE, Mohi A, Kakkassery V, Heindl LM (2020) Personalized medicine in the treatment of periocular tumors : targeted treatment and use of immune checkpoint inhibitors. Ophthalmologe Epub ahead of print. https://doi.org/10.1007/s00347-019-01034-z

Kakkassery V, Emmert S, Adamietz IA, Kovács G, Jünemann AM, Otte C, Zimbelmann M, Brosig A, Grisanti S, Heindl LM (2020) Alternative treatment options for periorbital basal cell carcinoma. Ophthalmologe 117:113–123. https://doi.org/10.1007/s00347-019-01021-4CrossRefPubMed

Mathis J, Doerr T, Lin E, Ibrahim SF (2019) Oral hedgehog pathway inhibition as a means for ocular salvage in locally advanced intraorbital basal cell carcinoma. Dermatol Surg 45:17–25. https://doi.org/10.1097/DSS.0000000000001640CrossRefPubMed

Kakkassery V, Loeffler KU, Sand M, Koch KR, Lentzsch AM, Nick AC, Adamietz IA, Heindl LM (2017) Current diagnostics and therapy recommendations for ocular basal cell carcinoma. Ophthalmologe 114:224–236. https://doi.org/10.1007/s00347-016-0370-1CrossRefPubMed

Ally MS, Aasi S, Wysong A, Teng C, Anderson E, Bailey-Healy I, Oro A, Kim J, Chang AL, Tang JY (2014) An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma. J Am Acad Dermatol 71:904–911. https://doi.org/10.1016/j.jaad.2014.05.020CrossRefPubMed

Dummer R, Guminski A, Gutzmer R et al (2016) The 12-month analysis from basal cell carcinoma outcomes with LDE225 treatment (BOLT): a phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma. J Am Acad Dermatol 75:113–125. https://doi.org/10.1016/j.jaad.2016.02.1226CrossRefPubMed

Title: Effective treatment of locally advanced periocular basal cell carcinoma with oral hedgehog pathway inhibitor?
Authors: Xiaoyi Hou
Alexander C. Rokohl
Monika Ortmann
Ludwig M. Heindl
Publication date: 01-10-2020
Publisher: Springer Berlin Heidelberg
Keywords: Basalioma
Basalioma
Basalioma
Basalioma
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 10/2020
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-020-04779-5

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Effective treatment of locally advanced periocular basal cell carcinoma with oral hedgehog pathway inhibitor?

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 10/2020

Long-term natural history of the idiopathic epiretinal membrane in children and young adults

Genotypic and phenotypic characteristics of Korean children with childhood-onset Leber’s hereditary optic neuropathy

What COVID-19 has taught us: lessons from around the globe

Accuracy evaluation of objective refraction using the wavefront aberrometer in pseudophakic eyes

Airborne pathogen projection during ophthalmic examination

Risk of SARS-CoV-2 transmission to medical staff and patients from an exposure to a COVID-19-positive ophthalmologist